Temperature-controlled radiofrequency ablation for the treatment of chronic rhinitis: Two-year outcomes from a prospective multicenter trial.

Masayoshi TakashimaJ Pablo StolovitzkyRandall A OwStacey L SilversChad M McDuffieMarc DeanAhmad R SedaghatBobby A Tajudeen

Published in: International forum of allergy & rhinology (2024)

TCRF ablation of the PNN is safe and resulted in a significant and sustained reduction in chronic rhinitis symptom burden through 2 years and a substantial reduction in concomitant medication burden.

Keyphrases

radiofrequency ablation
clinical trial
healthcare
risk factors
phase iii
randomized controlled trial
phase ii
combination therapy
catheter ablation